Literature DB >> 2674180

Rapid diagnosis of influenza infection of NP antigen using an immunocapture ELISA test.

J J Chomel1, D Thouvenot, M Onno, C Kaiser, J M Gourreau, M Aymard.   

Abstract

An immunocapture ELISA test for the diagnosis of human and animal influenza A and/or B is described. A monoclonal anti-nucleoprotein (NP) antibody was used to capture the NP antigen and the captured antigen was detected by an anti-NP polyclonal rabbit antiserum. Compared with the usual diagnostic method by cultivation in embryonated eggs, this test had a high specificity (97%) and sensitivity when used for diagnosis using clinical nasopharyngeal samples obtained from patients and animals. Immunocapture ELISA permitted an easier reading than the indirect immunofluorescence technique. It also permitted diagnosis in frozen samples (-20 degrees C) or in infected LLCMK2 cells mixed with uninfected nasopharyngeal cells and kept at 20 degrees C for one week. This test can be carried out in 3 h.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2674180     DOI: 10.1016/0166-0934(89)90102-x

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  11 in total

1.  Enhancing effect of centrifugation on isolation of influenza virus from clinical specimens.

Authors:  M Seno; Y Kanamoto; S Takao; N Takei; S Fukuda; H Umisa
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

2.  Direct detection of influenza virus antigen in nasopharyngeal specimens by direct enzyme immunoassay in comparison with quantitating virus shedding.

Authors:  G Döller; W Schuy; K Y Tjhen; B Stekeler; H J Gerth
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Influenza and influenza-like illness in general practice: drawing lessons for surveillance from a pilot study in Paris, France.

Authors:  F Carrat; A Tachet; B Housset; A J Valleron; C Rouzioux
Journal:  Br J Gen Pract       Date:  1997-04       Impact factor: 5.386

4.  Rapid detection of influenza A neuraminidase subtypes by cDNA amplification coupled to a simple DNA enzyme immunoassay.

Authors:  B Schweiger; I Lange; R Heckler; H Willers; E Schreier
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 5.  Influenza: diagnosis, management, and prophylaxis.

Authors:  M Wiselka
Journal:  BMJ       Date:  1994-05-21

6.  Evaluation of a competitive ELISA for antibody detection against avian influenza virus.

Authors:  Dae Sub Song; Youn Jeong Lee; Ok Mi Jeong; Yong Joo Kim; Chan Hee Park; Jung Eun Yoo; Woo Jin Jeon; Jun Hun Kwon; Gun Woo Ha; Bo Kyu Kang; Chul Seung Lee; Hye Kwon Kim; Byeong Yeal Jung; Jae Hong Kim; Jin Sik Oh
Journal:  J Vet Sci       Date:  2009-12       Impact factor: 1.672

7.  Rapid detection of influenza A virus infection utilizing an immunomagnetic bead-based microfluidic system.

Authors:  Kang-Yi Lien; Lien-Yu Hung; Tze-Bin Huang; Yi-Che Tsai; Huan-Yao Lei; Gwo-Bin Lee
Journal:  Biosens Bioelectron       Date:  2011-03-16       Impact factor: 10.618

8.  Specific and sensitive detection of Influenza A virus using a biotin-coated nanoparticle enhanced immunomagnetic assay.

Authors:  Carole Farre; Sara Viezzi; Alice Wright; Perrine Robin; Nathalie Lejal; Marisa Manzano; Jasmina Vidic; Carole Chaix
Journal:  Anal Bioanal Chem       Date:  2020-11-23       Impact factor: 4.142

9.  Limited cross-reactivity of mouse monoclonal antibodies against Dengue virus capsid protein among four serotypes.

Authors:  Megumi Noda; Promsin Masrinoul; Chaweewan Punkum; Chonlatip Pipattanaboon; Pongrama Ramasoota; Chayanee Setthapramote; Tadahiro Sasaki; Mikiko Sasayama; Akifumi Yamashita; Takeshi Kurosu; Kazuyoshi Ikuta; Tamaki Okabayashi
Journal:  Biologics       Date:  2012-11-26

10.  Epidemiology of viral infections and evaluation of the potential benefit of OM-85 BV on the virologic status of children attending day-care centers.

Authors:  M Aymard; J J Chomel; J P Allard; D Thouvenot; D Honegger; D Floret; J P Boissel; J P Collet; F Dürr; J Gillet
Journal:  Respiration       Date:  1994       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.